Effect of Microgravity on Spinal Anesthesia

Microgravity on Spinal Anesthesia

Disclaimer: This article is intended solely for informational and educational purposes only. It does not constitute medical advice.

As space agencies and private companies pursue longer missions in outer space, the possibility of a crew member needing medical treatment such as surgery far from a hospital is becoming a real concern. NASA identified traumatic injury as the biggest medical concern for mission success, and activities like spacewalks and spacecraft repairs increase the risk of trauma, musculoskeletal injury, hypoxia, and decompression sickness, among others.Risk analyses predict at least one surgical emergency will occur during a multi-year space mission to Mars with a standard crew of 7.2 General anesthesia requires breathing tubes, ventilators, and gas agents that could be dangerous or otherwise entirely impractical in a spacecraft cabin, making spinal anesthesia (which numbs the lower portion of the body while patient consciousness is preserved) a more practical option.3 

Still, spinal anesthesia depends on injected medication spreading predictably within the spinal canal, a process which is heavily influenced by gravity. On Earth, the natural curvature of the spine and the relative density of the anesthetic drug work together to control how far the medication spreads through the spinal fluid. In microgravity, removal of a sustained gravity vector eliminates the density-dependent layering that typically shapes anesthetic distribution on Earth. Therefore, mechanisms like CSF pulsatility, cardiorespiratory pressure oscillations, and injection-related mixing are expected to have a greater influence on anesthetic distribution, meaning the drug could spread more diffusely. This would make the effects of anesthesia more unpredictable, since no research has directly tested spinal anesthesia in microgravity conditions.3 

The cardiovascular system undergoes major shifts in microgravity, with fluid initially redistributing toward the head and cardiac output temporarily rising before stroke volume and plasma volume return to lower levels after several days of adaptation. Prolonged space flight weakens autonomic reflexes and lowers systemic vascular resistance, leaving the body less able to compensate for drops in blood pressure.4 This matters because spinal anesthesia commonly causes hypotension on Earth through gravity-dependent pooling of blood in the legs, a mechanism that would not apply in microgravity. Instead, any hypotension in space would more likely stem from reduced overall blood volume and impaired autonomic reflexes, meaning the risk and management of cardiovascular collapse during spinal anesthesia in space remains uncertain without further study.3 

The musculoskeletal system also changes considerably over time in microgravity, which has direct implications for how spinal anesthesia is delivered. Astronauts experience measurable spinal elongation and a flattening of the lower back’s natural curve,5 which are driven primarily by atrophy of the small muscles that support the spine. This muscle loss can be substantial, with studies showing significant reductions in lumbar muscle mass after long missions, alongside ongoing loss of bone density in the spine and hips. These structural changes make it harder to anticipate how a spinal block would behave in astronauts, especially after weeks or months in space.3 

Neurological adaptations to microgravity add another layer of complexity to spinal anesthesia. Changes in CSF volume, including enlargement of neural ventricles, could mean that achieving the same anesthetic effect in space might require adjusting drug dose, volume, or injection speed. Additionally, altered CSF flow patterns observed in ground-based analog studies suggest that the drug could spread higher or lower than expected, though the exact effect remains unknown.6 

Although spinal anesthesia is the most practical anesthetic option if surgical anesthesia is needed in confined and resource-limited space environments, the physiologic changes that occur in microgravity mean its performance cannot be assumed to match what is known in Earth-based practice. Current understanding rests almost entirely on indirect evidence from analog studies and observational space flight data, with no direct experience administering spinal anesthesia in orbit. As commercial space flight opens longer missions to a broader range of participants, further research will be essential to using this technique safely beyond Earth. 

References 

  1. Billica R. D., Simmons S. C., Mathes K. L., McKinley B. A., Chuang C. C., Wear M. L., Hamm P. B. (1996). Perception of the medical risk of spaceflight. Aviat. Space Environ. Med.67 (5), 467–473. 
  2. Summers, R. L., Johnston, S. L., Marshburn, T. H., & Williams, D. R. (2005). Emergencies in Space. Annals of Emergency Medicine, 46(2), 177–184. https://doi.org/10.1016/j.annemergmed.2005.02.010 
  3. Wagner, S., & Turnock, M. (2026). Physiologic changes in microgravity may lead to unpredictable effects of spinal anesthesia. Frontiers in Physiology, 17https://doi.org/10.3389/fphys.2026.1773665  
  4. Komorowski, M., Fleming, S., & Kirkpatrick, A. W. (2016). Fundamentals of Anesthesiology for Spaceflight. Journal of Cardiothoracic and Vascular Anesthesia, 30(3), 781–790. https://doi.org/10.1053/j.jvca.2016.01.007  
  5. Young, K. S., & Rajulu, S. (2020). Changes in seated height in microgravity. Applied Ergonomics, 83, 102995. https://doi.org/10.1016/j.apergo.2019.102995  
  6. Metterlein, T., Kuenzig, H., Bele, S., Brawanski, A., & Graf, B. M. (2010). Coma after spinal anaesthesia in a patient with an unknown intracerebral tumour. Acta Anaesthesiologica Scandinavica, 54(9), 1149–1151. https://doi.org/10.1111/j.1399-6576.2010.02286.x